Editas

New class of genome therapeutics.

Funded
Y-combinator Logo
Editas UI on MacBook Pro

Editas Medicine is the only company today whose mission is to translate genome editing technology into a novel class of human therapeutics that enables precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.

DNA molecule in all of its beauty is part of every bio medicine and genome orientated company or startup, and Povio Labs helped with the creation of the DNA molecule that can be seen on Editas' Homepage.

Businessinsider
A Bill Gates-backed startup that wants to edit your genes just raised nearly $100 million
Bloomberg
Gene-Editing Drugmaker Backed by Google, Gates Files for IPO
Bostonglobe
Editas Medicine raises $94.4 million in year’s first IPO
Project Stats

Quite amazing. Right?

$210M
Capital Raised
2016
Year of IPO
17
Investors on Board

Create tests for a website in plain English then run them across all major browsers with a single click.